Biotech Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests
NewsDealsSocialBlogsVideosPodcasts
Unnatural Products Secures $1.8B Cardio Pact with Novartis
CorporateBioTechHealthcareVenture Capital

Unnatural Products Secures $1.8B Cardio Pact with Novartis

BioWorld (Citeline) – Featured Feeds
BioWorld (Citeline) – Featured Feeds
•February 18, 2026
BioWorld (Citeline) – Featured Feeds
BioWorld (Citeline) – Featured Feeds•Feb 18, 2026
0

Participants

Unnatural Products

Unnatural Products

company

Novartis

Novartis

investor

Deal Summary

Biotech firm Unnatural Products announced a $1.8 billion partnership with pharmaceutical giant Novartis to develop cardiovascular therapies. The agreement includes a corporate investment from Novartis, marking a significant funding boost for Unnatural Products.

0

Comments

Want to join the conversation?

Loading comments...